Inogen, Inc · NASDAQ:INGN

Inogen — Q1 2026 Earnings Presentation

8 slides from Inogen's earnings presentation, May 7, 2026

  1. Slide 1: Q1 2026 Supplemental Financial Information

    May 7, 2026 Q1 2026 Supplemental Financial Information

  2. Slide 2: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures Inogen presents certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three months ended March 31, 2026, and March 31, 2025. Management believes these non-GAAP financial measures, when considered together with the most dire

  3. Slide 3: Q1 2026 Results

    Q1 2026 Results Revenue by geographic region Total by Category Q1 2026 Revenue Year-Over-Year Change % of Total Revenue U.S. sales $34.7 million (4.8)% 40.8% International sales $37.7 million 17.8% 44.3% U.S. rentals $12.7 million (8.0)% 14.9% Total revenue $85.1 million 3.4% 100% Total constant cur

  4. Slide 4: Operating Expense and Net Loss

    Operating Expense and Net Loss (in thousands) Three months ended March 31, 2026 2025 Operating expense Research and development $ 5,097 $ 4,034 Sales and marketing 24,603 23,757 General and administrative 17,499 16,237 Total operating expense 47,199 44,028 Loss from operations (9,336) (7,656) Other

  5. Slide 5: Reconciliation of GAAP to Non-GAAP

    Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended March 31, Non-GAAP EBITDA and Adjusted EBITDA 2026 2025 Net loss (GAAP) $ (8,324) $ (6,174) Non-GAAP adjustments: Interest income, net (880) (1,029) Benefit for income taxes (174) (97) Depreciation and amortization

  6. Slide 6: Reconciliation of GAAP to Non-GAAP

    Reconciliation of GAAP to Non-GAAP Adjusted Financial Results (in thousands) Three months ended March 31, 2026 Loss from Non-GAAP Financial Metrics Gross Profit Operating Expense Operations Net Loss Diluted EPS Financial Results (GAAP) $ 37,863 $ 47,199 $ (9,336) $ (8,324) $ (0.30) Reported percent

  7. Slide 7: Stock-Based Compensation

    Stock-Based Compensation (in thousands) Three months ended March 31, 2026 2025 Stock-based compensation expense by type of award: Restricted stock units and restricted stock awards $ 1,864 $ 2,008 Employee stock purchase plan 86 139 Total stock-based compensation expense $ 1,950 $ 2,147 Three months

  8. Slide 8: Improving lives through respiratory care.

    Improving lives through respiratory care.

Inogen — Q1 2026 Earnings Presentation on 6ix